JosephALucciIIIMD
Obstetrics & Gynecology • Houston, TXGynecologic Oncology
Professor of Obstetrics & Gynecology, University of Texas Health Science Center at Houston
Dr. Lucci is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
11914 Astoria Blvd
Suite 510
Houston, TX 77089Phone+1 713-486-1170Fax+1 713-500-0508- Is this information wrong?
Education & Training
University of California (Irvine)Fellowship, Gynecologic Oncology, 1988 - 1992- University of California (Irvine)Residency, Obstetrics and Gynecology, 1988 - 1992
Methodist Hospital (Houston)Residency, Obstetrics and Gynecology, 1984 - 1988
McGovern Medical School at UTHealthClass of 1984
Certifications & Licensure
CA State Medical License 1988 - Present
TX State Medical License 1985 - 2025
FL State Medical License 2004 - 2024- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- America's Top Doctors for Cancer Castle Connolly, 2009-2013
- Join now to see all
Clinical Trials
- Docetaxel and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer Start of enrollment: 2003 Sep 01
- Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line Chemotherapy Start of enrollment: 2007 Oct 01
- Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer Start of enrollment: 2012 Jan 09
Publications & Presentations
PubMed
- 1 citationsA phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chem...Robert W Holloway, Premal Thaker, Alberto A Mendivil, Sarfraz Ahmad, Ahmed N Al-Niaimi, James Barter, Tiffany Beck, Setsuko K Chambers, Robert L Coleman, Sarah M Craft...> ;International Journal of Gynecological Cancer. 2023 Sep 4
- The value of SOX2 in the differential diagnosis of SMARCA4 (BRG1)-deficient uterine neoplasms.Lan Zheng, Lin Zhang, Xiaohong Iris Wang, Guy Katz, Nidhi Tandon, Bihong Zhao, Joseph Lucci, Jianmin Ding, Songlin Zhang> ;Human Pathology. 2022 Jun 1
- 8 citationsPhase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancerArlene E. Garcia-Soto, Nathalie D. McKenzie, Margaret Whicker, J.M. Pearson, Edward A. Jimenez, Lorraine Portelance, Jennifer J. Hu, Joseph A. Lucci, Rehman Qureshi, A...> ;Cancer. 2021 Jul 1
- Join now to see all
Press Mentions
Thanks to Children's Memorial Hermann Hospital, a Mother's Scary Pregnancy Complication Has a Sweet EndingApril 12th, 2023
Grant Support
- Taxol With Radiotherapy For Carcinoma Of The CervixNational Center For Research Resources1998–1999
Professional Memberships
- Member
- Member
Hospital Affiliations
Memorial Hermann - Texas Medical CenterHouston, Texas
Memorial Hermann Greater Heights HospitalHouston, Texas
St. Joseph Medical CenterHouston, Texas
Memorial Hermann Southeast HospitalHouston, Texas
Memorial Hermann Southwest HospitalHouston, Texas
Memorial Hermann Memorial City Medical CenterHouston, Texas
Memorial Hermann Physician NetworkHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
